Home » Authors » Mark McCarty

Articles by Mark McCarty

Neuronetics 510(k) for depression stalls at advisory panel meeting

Jan. 30, 2007

By Mark McCarty

Congress bills seek to corral long-term care hospitals

Jan. 26, 2007

By Mark McCarty

White House crafts healthcare coverage plan via tax breaks

Jan. 24, 2007

By Mark McCarty

ACP: Fed must shift payment to quality, physician engagement

Jan. 23, 2007

By Mark McCarty

NHLBI campaign tackles COPD as public health/research priority

Jan. 19, 2007

By Mark McCarty

E-prescribing software offering seeks to reduce drug errors<

Jan. 18, 2007

By Mark McCarty

CBO: Social Security, Medicare ‘imprudent and unsustainable’

Jan. 18, 2007

By Mark McCarty

E-prescribing software offering seeks to reduce drug errors

Jan. 17, 2007

By Mark McCarty

Despite rising healthcare costs, consumer share relatively flat

Jan. 16, 2007

By Mark McCarty

Thermal meter gives diabetics chance to stave off foot ulcers

Jan. 11, 2007

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.